Azelaic Acid vs Tranexamic Acid
Which is right for your skin?
Both target marks: Azelaic acid is best for post-acne redness and active breakouts; Tranexamic acid targets deep-seated pigmentation and melasma. Red marks → azelaic; brown patches → tranexamic.
Calms redness, fades acne marks, and clears bumps, all without aggravating sensitive skin. Pregnancy-safe.
Fades stubborn dark patches like melasma and deep marks left behind by acne or hormonal shifts. The one to reach for when other brighteners haven't worked.
Can you use Azelaic Acid and Tranexamic Acid together?
We have no documented layering conflict between Azelaic Acid and Tranexamic Acid. Introduce one at a time and patch-test.
You want anti-acne, brightening, anti-inflammatory. Calms redness, fades acne marks, and clears bumps, all without aggravating sensitive skin. Pregnancy-safe.
You want brightening. Fades stubborn dark patches like melasma and deep marks left behind by acne or hormonal shifts. The one to reach for when other brighteners haven't worked.
Cited research
Petrovici AG et al., A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations, Pharmaceuticals (Basel) 2025
Feng Y et al., Azelaic Acid: Mechanisms of Action and Clinical Applications, Clinical, Cosmetic and Investigational Dermatology 2024;17:2359-2371 — antibacterial, anti-keratinizing, antimelanogenic, antioxidant, and anti-inflammatory; FDA-approved for papulopustular rosacea
King A et al., A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging, Journal of Cosmetic Dermatology 2023;22(10):2650-2662 — azelaic acid more effective than vehicle for rosacea, acne, and melasma; aging evidence limited
Liu H et al., Topical agents for acne (covers azelaic arm), Cochrane Database of Systematic Reviews 2020;5:CD011368 — conclusion: clinical benefit is unclear
Sieber MA, Hegel JK, Azelaic acid: properties and mode of action, Skin Pharmacology and Physiology 2014;27 Suppl 1:9-17
CIR Final Report on the Safety Assessment of Dicarboxylic Acids, Salts, and Esters (covers azelaic acid as C9 dicarboxylic acid), International Journal of Toxicology 2012
Iraji F et al., Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris, Indian Journal of Dermatology, Venereology and Leprology 2007;73(2):94-96 — double-blind RCT: 20% azelaic acid gel reduced total lesion count 60.6% vs 19.9% placebo (P=0.002)
Gupta AK, Gover MD, Azelaic Acid (15% Gel) in the Treatment of Acne Rosacea, International Journal of Dermatology 2007
Thiboutot D, Thieroff-Ekerdt R, Graupe K, Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies, Journal of the American Academy of Dermatology 2003;48(6):836-845 — AzA gel statistically superior to vehicle (58% vs 40% and 51% vs 39% inflammatory-lesion reduction)
Liang Y et al., Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta-analysis, Journal of Cosmetic Dermatology 2024 — oral TXA + topical agents most effective delivery route
Tranexamic Acid Ameliorates Skin Hyperpigmentation by Downregulating Endothelin-1 Expression in Dermal Microvascular Endothelial Cells, Annals of Dermatology 2024;36(3):151-162 — mechanism study showing oral TXA suppresses endothelin-1 in vascular endothelial cells
Calacattawi R, Alshahrani M, Aleid M et al., Tranexamic acid as a therapeutic option for melasma management: a meta-analysis and systematic review of randomized controlled trials, Journal of Dermatological Treatment 2024;35(1):2361106 — pooled RCT evidence that tranexamic acid significantly reduces melasma severity via plasmin-inhibition of UV-triggered melanogenesis
Ding Y et al. Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment. Pigment Cell Melanoma Res. 2023;36(6):460-473. doi:10.1111/pcmr.13108 — Review of Riehl's melanosis that specifically identifies oral tranexamic acid among therapies showing improved effectiveness.
Feng X et al., Efficacy and safety of tranexamic acid in the treatment of adult melasma: An updated meta-analysis of randomized controlled trials, Journal of Clinical Pharmacy and Therapeutics 2021 — oral TXA is effective and safe for melasma, especially as adjuvant
Nautiyal A, Wairkar S. Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell Melanoma Res. 2021;34(6):1000-1014. doi:10.1111/pcmr.12986 — Comprehensive review identifying oral tranexamic acid as a first-line oral therapeutic agent for hyperpigmentation management.
Anwar AI et al., Randomized control trial outcomes of tranexamic acid combination serum as a depigmenting agent, Dermatologic Therapy 2019
Tranexamic Acid Diminishes Laser-Induced Melanogenesis, Annals of Dermatology 2015;27(3):250-256 — TXA reduces melanin production and tyrosinase activity in melanocytes; candidate for post-inflammatory hyperpigmentation
Na JI et al., Effect of tranexamic acid on melasma: a clinical trial with histological evaluation, Journal of the European Academy of Dermatology and Venereology 2013 — topical TXA reduced melasma severity with corresponding histological pigment reduction
Maeda K, Naganuma M, Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation, Journal of Photochemistry and Photobiology B 1998;47(2-3):136-41
Every entry points to a specific paper or regulatory document. See methodology for what each outcome label means.